Pulmozyme and Neutrophil count increased - a phase IV clinical study of FDA data

Summary:

Neutrophil count increased is reported as a side effect among people who take Pulmozyme (dornase alfa), especially for people who are female, 10-19 old, have been taking the drug for 6 - 12 months also take Tobi, and have Cystic fibrosis lung.

The phase IV clinical study analyzes which people have Neutrophil count increased when taking Pulmozyme. It is created by eHealthMe based on reports of 19,995 people who have side effects when taking Pulmozyme from the FDA, and is updated regularly.

What is Pulmozyme?

Pulmozyme has active ingredients of dornase alfa. It is often used in cystic fibrosis. eHealthMe is studying from 20,012 Pulmozyme users. Check the latest studies of Pulmozyme.

What is Neutrophil count increased?

Neutrophil count increased (excess than normal number of neutrophil a type of blood cell) is found to be associated with 943 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Neutrophil count increased.

On Aug, 13, 2026

19,995 people reported to have side effects when taking Pulmozyme.
Among them, 12 people (0.06%) have Neutrophil count increased.

Could Pulmozyme cause Neutrophil count increased?

Among these 12 people:

How long have people been on Pulmozyme when they have Neutrophil count increased? *

What is the gender of people who have Neutrophil count increased when taking Pulmozyme? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Neutrophil count increased when taking Pulmozyme? *

What are other drugs people take besides Pulmozyme? *

What are other side effects people have besides Neutrophil count increased? *

Dyspnea (difficult or laboured breathing): 10 people, 83.33%
Cough: 9 people, 75.00%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 9 people, 75.00%
Blood Calcium Decreased: 8 people, 66.67%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 8 people, 66.67%
Chest Pain: 7 people, 58.33%
Eosinophil Count Increased: 6 people, 50.00%
Fatigue (feeling of tiredness): 6 people, 50.00%
Red Blood Cell Count Increased: 6 people, 50.00%
Concomitant Disease Aggravated (advanced due to some of accompanying): 5 people, 41.67%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 75.00%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 9 people, 75.00%
Nausea (feeling of having an urge to vomit): 7 people, 58.33%
Pain: 7 people, 58.33%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 41.67%
Depression: 5 people, 41.67%
Chest Pain: 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Hypersensitivity: 3 people, 25.00%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmozyme and have Neutrophil count increased?

- Check whether Neutrophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmozyme:

Pulmozyme (20,012 reports)

Browse all side effects of Pulmozyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil count increased:

Neutrophil count increased (943 drugs)

Browse all the conditions that are associated with Neutrophil count increased:

Neutrophil count increased (1,170 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dornase alfa (the active ingredients of Pulmozyme) and Pulmozyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.